Pipeline · Bill → Law
Step 1
Introduced
Jan 9, 2023
Step 2
Referred
Dec 17, 2024
E&C · Ways & Means
Step 3
Committee
Dec 6, 2023
Reported out
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary
This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.
Timeline · 14 actions
Dec 19, 2024
Committee on Ways and Means discharged.
Dec 19, 2024
Placed on the Union Calendar, Calendar No. 779.
Dec 17, 2024
Referred to the Subcommittee on Health.
Nov 22, 2024
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-764, Part I.
Nov 22, 2024
House Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.
Dec 6, 2023
Committee Consideration and Mark-up Session Held
Dec 6, 2023
Ordered to be Reported (Amended) by the Yeas and Nays: 42 - 0.
Dec 5, 2023
Committee Consideration and Mark-up Session Held
Nov 15, 2023
Subcommittee Consideration and Mark-up Session Held
Nov 15, 2023
Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by Voice Vote.
Jan 20, 2023
Referred to the Subcommittee on Health.
Jan 9, 2023
Introduced in House
Jan 9, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 9, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.